Larimar Therapeutics Inc

Flynn James E’s block buys at Larimar Therapeutics signal insider confidence; see how this could boost stock momentum yet pose liquidity risks.

Insider buying shows Larimar Therapeutics’ confidence: key execs buying at $5.00, a 77% weekly gain, and strong analyst upgrades signal potential upside.

Insider buying at Larimar Therapeutics shows executives’ confidence, with large RSU and option purchases hinting at a potential rebound amid volatility.